Concepedia

David A. Perrey

DA

Statistics

Publications

15

Citations

375

H-Index

13

Active since

1995

Affiliations

RTI International(Current)

University at Buffalo, State University of New York

Merck & Co., Inc., Rahway, NJ, USA (United States)

Scynexis (United States)

Parker Hughes Cancer Center

David A. Perrey is an author at RTI International specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1995–2023

15

Publications

15

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part I

Andrew Scribner, Richard Dennis, Jean S. Hong et al. · European Journal of Medicinal Chemistry · 2007 · 52 citations · Full text

, , +12

Substituted Tetrahydroisoquinolines as Selective Antagonists for the Orexin 1 Receptor

David A. Perrey, Nadezhda German, Brian P. Gilmour et al. · Journal of Medicinal Chemistry · 2013 · 41 citations · Full text

, , +17

Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II

Andrew Scribner, Richard Dennis, Shuliang Lee et al. · European Journal of Medicinal Chemistry · 2007 · 37 citations

, , +13

Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling

K. A. Levy, Zachary D. Brodnik, Jessica K. Shaw et al. · Psychopharmacology · 2017 · 36 citations · Full text

, , +16

Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates

Huiping Ding, Norikazu Kiguchi, David A. Perrey et al. · British Journal of Anaesthesia · 2020 · 34 citations · Full text

, , +14

1–5 of 15